Sponsored by:
Decentralised Clinical Trials In The EU
DCTs can take a variety of forms depending on patients’ needs, study protocol, drug company preferences, or regulatory requirements.
Trials may be remote and decentralised from start to finish-with no physical contact between participants and investigators—or they may rely on hybrid designs that incorporate only certain elements of decentralization.
